Emergent Biosolutions
Global Life Science Company
Based in MD
🤖
AI Overview
With $360K in lobbying spend across 13 quarterly filings, Emergent Biosolutions is an active lobbying client. Their lobbying covers 6 issue areas. Active from 2019 to 2021.
$360K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Disaster Planning, Budget/Appropriations, Homeland Security, Defense, Health Issues and 1 more
- •FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
- •Re-authorization of the Pandemic and All-Hazards Preparedne
- •FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
- •Re-authorization of the Pandemic and All-Hazards Preparednes
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.